Melatonin MT1 Receptor in Triple Negative Breast Carcinoma (TNBC) and Estrogen Receptor Positive Invasive Ductal Carcinoma (ER plus OC)

被引:0
|
作者
Oprea-Ilies, G. M.
Hans, E.
Sackett-Lundeen, L. L.
Sullivan, H.
Bush, R.
Adams, A.
Cohen, C.
机构
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Reg Hosp, St Paul, MN USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
228
引用
收藏
页码:57A / 57A
页数:1
相关论文
共 50 条
  • [41] Characterization of Estrogen Receptor Negative/Progesterone Receptor Positive/(ER-/PR plus ) Breast Cancer (BC)
    Shen, Tiansheng
    Brandwein-Gensler, Margaret
    Hameed, Omar
    Siegal, Gene
    Wei, Shi
    LABORATORY INVESTIGATION, 2015, 95 : 65A - 65A
  • [42] DISTRIBUTION OF ESTROGEN-RECEPTOR IN DUCTAL CARCINOMA INSITU OF THE BREAST
    CHAUDURI, B
    MUCCI, S
    MALAFA, M
    CHAUDHURI, PK
    SURGERY, 1993, 113 (02) : 134 - 137
  • [43] Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line
    Watanabe, Mari
    Kobayashi, Yoichi
    Takahashi, Noriyuki
    Kiguchi, Kazushige
    Ishizuka, Bunpei
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (04) : 567 - 573
  • [44] Expression of folate receptor alpha in ductal carcinoma in situ of the breast and comparison with that of invasive ductal carcinoma
    Zhang, Z.
    Wang, J.
    Tacha, D.
    Li, P.
    Bremer, R.
    Skinner, K.
    Hicks, D. G.
    Bu, H.
    Tang, P.
    CANCER RESEARCH, 2013, 73
  • [45] Evaluating Surgical Outcomes Between Estrogen Receptor Positive Invasive Lobular and Invasive Ductal Carcinoma of the Breast-A Propensity Matched Analysis
    O'Connor, Domhnall J.
    Davey, Matthew G.
    Mcfeetors, Carson
    Mclaughlin, Ray P.
    Sweeney, Karl J.
    Barry, Michael K.
    Malone, Carmel M.
    Abd El Wahab, Sami
    Lowery, Aoife J.
    Kerin, Michael J.
    CLINICAL BREAST CANCER, 2024, 24 (08) : e655 - e662
  • [46] Apocrine Carcinomas Are a Distinct Subset of Androgen Receptor Positive (AR plus ) Triple Negative Breast Carcinomas (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    LABORATORY INVESTIGATION, 2017, 97 : 30A - 30A
  • [47] Apocrine Carcinomas Are a Distinct Subset of Androgen Receptor Positive (AR plus ) Triple Negative Breast Carcinomas (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    MODERN PATHOLOGY, 2017, 30 : 30A - 30A
  • [48] Does estrogen receptor-negative/progesterone receptor-positive breast carcinoma exist? Reply
    Rakha, Emad A.
    Ellis, Ian O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 336 - 338
  • [49] Integration of Androgen Receptor (AR) Expression to Predict Survival for Triple-Negative Breast Carcinoma (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    MODERN PATHOLOGY, 2016, 29 : 30A - 30A
  • [50] Estrogen receptor-negative, progesterone receptor-positive breast carcinoma - Poor clinical outcome
    Keshgegian, AA
    Cnaan, A
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1996, 120 (10) : 970 - 973